Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 764 of 6351
-
Stroke survivors: which statin combo cuts recurrence best?
Disease control Recruiting nowAlong with the current clinical trial, the impact of adding atorvastatin or rosuvastatin in the first 24 hours on the clinical outcomes of first-ever large-vessel ischemic stroke patients treated with clopidogrel assessed through NIHSS, mRS, and possible adverse effects.
Phase 3 • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 26, 2026 14:07 UTC
-
Could a statin right after a stroke stop a second one?
Disease control Recruiting nowAlong with the current clinical trial, the impact of adding atorvastatin or rosuvastatin in the first 24 hours on the clinical outcomes of first-ever small vessel stroke patients treated with clopidogrel and aspirin assessed through NIHSS, mRS, and possible adverse effects.
Phase 3 • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug targets 13 cancers in major trial
Disease control Recruiting nowThis study is designed to assess the efficacy and safety of ifinatamab deruxtecan (I-DXD) in the following tumor types: endometrial cancer (EC); head and neck squamous cell carcinoma (HNSCC); pancreatic ductal adenocarcinoma (PDAC); colorectal cancer (CRC); hepatocellular carcino…
Phase 1/2 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New drug targets Hard-to-Treat breast cancers
Disease control CompletedThe primary purpose of the Dose Optimization (Part 1) of this study is to assess the safety and tolerability of BB-1701 and to determine the recommended dose (RD) of BB-1701 for Dose Expansion (Part 2). The primary purpose of Dose Expansion (Part 2) is to assess the antitumor act…
Phase 2 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New weekly shot could help control blood sugar in type 2 diabetes
Disease control CompletedThe purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and inadequate glycemic control. The study will last about 11 months and may include up to 11 visits.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can pressurized breathing boost mucus clearance in lung disease?
Disease control OngoingThe goal of this clinical trial is to determine if positive pressure during inspiration will improve penetration of aerosolized N-Acetylcysteine (NAC) into airway mucus plugs in the lungs of patients with asthma or Chronic Obstructive Pulmonary Disease (COPD). The main questions…
Phase 4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
New bladder cancer device could delay return of tumors without removing bladder
Disease control OngoingThe purpose of this study is to compare disease free survival (DFS) in participants with recurrence of papillary-only high-risk non-muscle-invasive bladder cancer (HR-NMIBC) within 1 year of last dose of Bacillus Calmette-Guérin (BCG) therapy and who refused or are unfit for Radi…
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Lung 'Zapping' procedure could slash severe asthma attacks in Hard-to-Treat patients
Disease control Recruiting nowRationale: For patients with severe asthma that remain uncontrolled with exacerbations despite biologics or patients who are not eligible for biologics, there is no reimbursed treatment other than pulmonary rehabilitation in the Netherlands. Pulmonary rehabilitation is known to h…
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Hope for women with recurrent pregnancy failure: new drug combo trial
Disease control Recruiting nowA Prospective Randomized Controlled Trial, the goal of this clinical trial is to evaluate the efficacy and safety of doxycycline alone versus doxycycline plus medroxyprogesterone acetate (MPA) in women with chronic endometritis (CE), and to assess subsequent reproductive outcomes…
Sponsor: Fang Wang • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a bone cement antibiotic stop infections after open leg fractures?
Prevention Recruiting nowThe goal of this randomized clinical trial is to study the best treatment for open lower leg fractures to prevent infection. The main questions it aims to answer is if treating tibia fracture patients with a calcium sulfate antibiotic depot is better at preventing infection that …
Phase 3 • Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Jul 09, 2026 00:00 UTC
-
New weekly diabetes shot shows promise in large trial
Disease control CompletedThis is a randomized, open-label, dulaglutide-controlled, multicenter Phase 3 trial to evaluate the efficacy, safety, and immunogenicity of different doses of TG103 injection in combination with metformin in subjects with type 2 diabetes with poor glycemic control treated with me…
Phase 3 • Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New program aims to prevent suicide in black teens
Knowledge-focused Recruiting nowThe overall goal of this study is to respond to the urgent need for an effective suicide prevention strategy for Black youth by examining the effectiveness of a systems-level strategy to recognize and respond to suicide risk among Black adolescents who present to emergency depart…
Sponsor: New York University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New combo pill attack targets Hard-to-Treat breast cancer
Disease control Recruiting nowThis study has as goal to evaluate the use of abemaciclib and bicalutamide in androgen receptor positive metastatic triple negative breast cancer.
Phase 2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Phone-Based fitness program aims to cut heart disease in african american women
Disease control Recruiting nowThe purpose of this study is to test a culturally tailored, smartphone-delivered intervention designed to increase physical activity and reduce risk for heart disease and type 2 diabetes among African American women.
Phase 2 • Sponsor: Arizona State University • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a tiny implant fix a leaky heart valve without open surgery?
Disease control Recruiting nowAn early feasibility study to evaluate the safety and feasibility of the MRace Implant and Delivery System to treat severe mitral regurgitation and to gather preliminary data on its performance thereby providing guidance for future clinical development. The study is a single-arm …
Sponsor: Polares Medical SA • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could a shot clear up acne? new mRNA vaccine trial begins
Disease control Recruiting nowThe purpose of the trial is to evaluate the safety, efficacy and immunogenicity of up to 3 intramuscular injections of the Acne mRNA vaccine candidate at up to four dose levels in adult participants aged 18 to 45 years with moderate to severe acne. This trial will consist of a C…
Phase 1/2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New combo therapy aims to deepen remission in multiple myeloma
Disease control OngoingThe goal of this clinical trial is to compare a maintenance therapy consisting of iberdomide and isatuximab with an iberdomide-only regimen. The trial is the subsequent maintenance therapy to GMMG-HD8/DSMM XIX trial for patients with newly-diagnosed multiple myeloma. Patients wit…
Phase 3 • Sponsor: University of Heidelberg Medical Center • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Engineered immune cells take on recurrent head and neck cancer
Disease control Recruiting nowThe purpose of this study is to test the safety and tolerability of using a new treatment called autologous T lymphocyte chimeric antigen receptor cells against the CSPG4 antigen (iC9.CAR-CSPG4 T cells) in patients with head and neck cancer that came back after receiving standard…
Phase 1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New implant aims to shrink deadly belly aneurysms and prevent rupture
Disease control OngoingTo determine the safety and effectiveness of IMPEDE-FX RapidFill to increase the percentage of subjects with shrinkage of the abdominal aortic aneurysm sac when used as an adjunct to on-label endovascular aneurysm repair (EVAR) stent graft treatment in trial subjects considered c…
Sponsor: Shape Memory Medical, Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New ointment could ease blistering in rare skin disease
Disease control OngoingThe proposed Phase 2/3 trial with double-blind and open-label extension phases is an international, multicenter study designed to assess the efficacy and safety of diacerein 1% ointment in patients with generalized EBS.
Phase 2/3 • Sponsor: TWi Biotechnology, Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC